package rules.treatment

import domain.Symptom;
import domain.SymptomType;
import engine.Scorecard;
import domain.Domain;

global Scorecard score;
dialect "java"

// ------------ GENERAL TREATMENT------------------------
rule "General treatment: hydroxychloroquine"
    salience 100
when
    eval(score.isEntryEligible() && score.total() >= 10)
then
    score.addTreatment(
        "Hydroxychloroquine 200–400 mg/day for all patients with SLE unless contraindicated. " +
        "Dose ≤5 mg/kg/day. Reduces flares and improves survival (EULAR 2019–2023). " +
        "Annual ophthalmologic monitoring recommended."
    );
end


rule "General treatment: glucocorticoid minimization"
    salience 95
when
    eval(score.isEntryEligible() && score.total() >= 10)
then
    score.addTreatment(
        "Use glucocorticoids only as short-term bridging therapy. " +
        "Aim for prednisone ≤5 mg/day with withdrawal if possible. " +
        "(EULAR 2023)."
    );
end


rule "General treatment: glucocorticoid dose reduction"
    salience 90
when
    eval(score.isEntryEligible() && score.total() >= 10)
then
    score.addTreatment(
        "Use the lowest effective glucocorticoid dose. " +
        "Target maintenance prednisone ≤7.5 mg/day with gradual tapering."
    );
end


// ------------RENAL DOMAIN---------------------------------
rule "Renal treatment: active lupus nephritis class III/IV or V"
    salience 85
when
    eval(score.total() >= 10 && score.getPointsForDomain(Domain.RENAL) >= 8)
then
    score.addTreatment(
        "Lupus nephritis class III/IV/V: " +
        "Induction therapy with mycophenolate mofetil (preferred) or cyclophosphamide. " +
        "Maintenance with mycophenolate or azathioprine. " +
        "High-dose IV corticosteroid pulses for severe flares."
    );
end

// ------------ CUTANEOUS DOMAIN ----------------------------
rule "Cutaneous treatment: acute or discoid lupus"
    salience 80
when
    eval(score.total() >= 10 && score.getPointsForDomain(Domain.MUCUTANEOUS) >= 4)
then
    score.addTreatment(
        "Cutaneous lupus (acute/discoid): strict photoprotection (SPF ≥50). " +
        "Topical corticosteroids or calcineurin inhibitors for localized lesions. " +
        "If skin disease remains refractory despite baseline antimalarial therapy, consider methotrexate or other systemic steroid-sparing agents."
    );
end

// --------------NEUROPSYCHIATRIC DOMAIN-------------------------------
rule "Neuropsychiatric treatment"
    salience 75
when
    eval(score.total() >= 10 && score.getPointsForDomain(Domain.NEUROPSYCHIATRIC) >= 3)
then
    score.addTreatment(
        "Neuropsychiatric lupus (psychosis / seizures): " +
        "high-dose IV methylprednisolone pulses followed by oral taper, " +
        "plus cyclophosphamide as first-line immunosuppressant in severe inflammatory NPSLE. " +
        "Rituximab may be considered in refractory or contraindicated cases. " +
        "Always add symptomatic treatment (anticonvulsants, antipsychotics, etc.) and manage contributing factors."
    );
end

// --------------MUSCULOSKELETAL DOMAIN-----------------------------
rule "Musculoskeletal treatment: arthritis or myalgia"
    salience 70
when
    eval(score.total() >= 10 && score.getPointsForDomain(Domain.MUSCULOSKELETAL) >= 6)
then
    score.addTreatment(
        "Musculoskeletal lupus (arthritis): " +
        "• NSAIDs for mild symptoms, only if no renal or cardiovascular contraindication. " +
        "• If symptoms persist, use low-dose prednisone (≤7.5 mg/day). " +
        "• For steroid-sparing therapy: methotrexate is first-line; alternatives include leflunomide or azathioprine."
    );
end

// --------------HEMATOLOGIC DOMAIN---------------------------------
rule "Hematologic treatment"
    salience 65
when
    eval(score.total() >= 10 && score.getPointsForDomain(Domain.HEMATOLOGIC) >= 3)
then
    score.addTreatment(
        "Hematologic manifestations: oral prednisone or intravenous pulses depending on severity. " +
        "Leukopenia alone may not require immunosuppression. " +
        "If refractory thrombocytopenia or hemolytic anemia, consider intravenous immunoglobulins or rituximab."
    );
end

// --------SEROSAL DOMAIN------------------------------
rule "Serosal treatment"
    salience 60
when
    eval(score.total() >= 10 && score.getPointsForDomain(Domain.SEROSAL) >= 5)
then
    score.addTreatment(
        "Serosal involvement: NSAIDs for mild pleuritis or pericarditis. " +
        "If inadequate response, use low-dose prednisone (≤0.5 mg/kg/day). " +
        "For recurrent pericarditis, add colchicine. " +
        "Maintain hydroxychloroquine in all patients unless contraindicated."
    );

end

// ------------IMMUNOLOGICAL DOMAIN---------------------------------
rule "Immunologic treatment: antibodies and complement"
    salience 55
when
    eval(
            score.total() >= 10 &&
            ( score.getPointsForDomain(Domain.SLE_SPECIFIC_ABS) >= 6 ||
              score.getPointsForDomain(Domain.APL) >= 2 ||
              score.getPointsForDomain(Domain.COMPLEMENT) >= 3 )
    )
then
    score.addTreatment(
            "Significant immunologic activity: maintain HCQ and add steroid-sparing immunosuppression " +
            "(azathioprine, mycophenolate, methotrexate) depending on organ involvement. " +
            "High-risk aPL without thrombosis: consider low-dose aspirin."
        );
end

rule "APS with thrombosis: anticoagulation"
    salience 52
when
    Symptom(type == SymptomType.APL, present == true)
    and Symptom(type == SymptomType.THROMBOSIS, present == true)
then
    score.addTreatment(
        "APS with thrombosis: long-term anticoagulation with warfarin (EULAR 2023)."
    );
end


rule "High-risk aPL without thrombosis: aspirin"
    salience 51
when
    Symptom(type == SymptomType.APL, present == true)
    and not Symptom(type == SymptomType.THROMBOSIS, present == true)
then
    score.addTreatment(
        "High-risk aPL profile without thrombosis: consider low-dose aspirin."
    );
end

rule "Fallback: further diagnostic evaluation required"
    salience 5
when
   eval(!score.isEntryEligible() || score.total() < 10)
       and eval(score.hasDifferentials())
then
    score.addTreatment(
        "Further diagnostic evaluation is required to confirm or rule out diseases in the differential list. " +
        "Current clinical and immunological data are insufficient for a definitive diagnosis."
    );
end


rule "DDX follow-up: Sjogren"
    salience 4
when
    eval(score.hasDifferentialName("Sjögren syndrome"))
then
    score.addTreatment(
        "Sjögren suspected: consider Schirmer test, salivary gland ultrasound, anti-SSA/SSB titers, and minor salivary gland biopsy if needed."
    );
end


rule "DDX follow-up: Drug-induced lupus"
    salience 4
when
    eval(score.hasDifferentialName("Drug-induced lupus (DIL)"))
then
    score.addTreatment(
        "Suspected drug-induced lupus: review medication history, check anti-histone antibodies, and assess improvement after drug withdrawal."
    );
end

rule "DDX follow-up: Myositis"
    salience 4
when
    eval(score.hasDifferentialName("Inflammatory myopathy"))
then
    score.addTreatment(
        "Myositis suspected: check CK, aldolase, EMG, muscle MRI, and myositis-specific antibodies (MDA5, Mi-2, TIF1γ, etc.)."
    );
end

rule "DDX follow-up: MCTD"
    salience 4
when
    eval(score.hasDifferentialName("Mixed connective tissue disease (MCTD)"))
then
    score.addTreatment(
        "MCTD suspected: evaluate anti-U1-RNP titers, Raynaud pattern, swollen fingers, and muscle involvement."
    );
end

rule "DDX follow-up: ANCA vasculitis"
    salience 4
when
    eval(score.hasDifferentialName("ANCA-associated vasculitis"))
then
    score.addTreatment(
        "ANCA vasculitis suspected: consider ANCA titers (PR3/MPO), urinalysis for hematuria, kidney function, chest CT for pulmonary involvement."
    );
end

rule "DDX follow-up: Viral mimicker"
    salience 4
when
    eval(score.hasDifferentialName("Viral mimic of SLE"))
then
    score.addTreatment(
        "Viral infection suspected: consider PCR or serology for EBV, CMV, Parvovirus B19; avoid immunosuppression until ruled out."
    );
end



